Last Updated: August 9, 2026

Litigation Details for Evolution Nutraceuticals Incorporated v. ThermoLife International LLC (D. Ariz. 2025)

✉ Email this page to a colleague

« Back to Dashboard

Evolution Nutraceuticals Incorporated v. ThermoLife International LLC (D. Ariz. 2025)

Docket	⤷ Start Trial	Date Filed	2025-02-12
Court	District Court, D. Arizona	Date Terminated
Cause	28:2201 Declaratory Judgment	Assigned To	Diane Joyce Humetewa
Jury Demand	Both	Referred To
Patents	8,013,002
Link to Docket	External link to docket

Small Molecule Drugs cited in Evolution Nutraceuticals Incorporated v. ThermoLife International LLC

The small molecule drug covered by the patent cited in this case is ⤷ Start Trial .

Details for Evolution Nutraceuticals Incorporated v. ThermoLife International LLC (D. Ariz. 2025)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2025-02-12				External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Litigation Summary and Analysis: Evolution Nutraceuticals Inc. v. ThermoLife International LLC (E.D. Texas, 2:25-cv-00461)

Last updated: July 24, 2026

No complete, case-specific litigation record (docket entries, pleadings, claims, asserted patent numbers, venue/judge details, or court orders) is present in the provided information to produce an accurate infringement, validity, or injunction analysis tied to 2:25-cv-00461.

What claims are at issue in Evolution Nutraceuticals v. ThermoLife (2:25-cv-00461)?

Answer: Not determinable from the information provided.

Which cause(s) of action are typically pleaded in this case category?

Not determinable from the information provided.

What patents or trade secrets does the complaint assert in 2:25-cv-00461?

Answer: Not determinable from the information provided.

Which asserted subject matter drives the infringement and damages theory?

Not determinable from the information provided.

What is the procedural posture of the case (motions to dismiss, TRO, preliminary injunction)?

Answer: Not determinable from the information provided.

What has the court decided so far?

Not determinable from the information provided.

What defenses does ThermoLife raise (non-infringement, invalidity, unenforceability, standing, preemption)?

Answer: Not determinable from the information provided.

Are there any claim-construction disputes or early technical issues?

Not determinable from the information provided.

How strong are the asserted claims based on the litigation posture?

Answer: Not determinable from the information provided.

What would materially move the case outcome?

Not determinable from the information provided.

What settlement or licensing risks exist for ThermoLife in this dispute?

Answer: Not determinable from the information provided.

Is there any indication of a consent judgment, covenants, or partial settlement?

Not determinable from the information provided.

What does this lawsuit mean commercially for both companies?

Answer: Not determinable from the information provided.

Revenue exposure tied to product volume and exclusivity

Not determinable from the information provided.

What generic or competitor entry risks arise from the asserted IP, if any?

Answer: Not determinable from the information provided.

Timing and regulatory drivers

Not determinable from the information provided.

Is there parallel litigation involving the same parties or IP?

Answer: Not determinable from the information provided.

Related cases in other districts or ITC proceedings

Not determinable from the information provided.

Key Takeaways

Case-specific litigation analysis cannot be produced from the provided inputs.
No accurate summary of asserted claims, patents, defenses, or court decisions can be stated for docket number 2:25-cv-00461 without docket-level record details.

FAQs

What court is handling Evolution Nutraceuticals v. ThermoLife (2:25-cv-00461)?
Not determinable from the information provided.
Did the plaintiff seek a temporary restraining order or preliminary injunction?
Not determinable from the information provided.
Which IP rights are asserted (patent, trade dress, trade secret, copyright, trademark)?
Not determinable from the information provided.
What defenses are raised in the response or motion practice?
Not determinable from the information provided.
What is the expected trial schedule or next major hearing date?
Not determinable from the information provided.

References (APA)

Evolution Nutraceuticals Incorporated v. ThermoLife International LLC, No. 2:25-cv-00461 (E.D. Texas).

More… ↓

⤷ Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.